GlassScriptPhysician profile
Emily Wagner
NPI 1811471709
$1,371.84
in general payments reported to CMS, 2019-2025
10 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $265 · 2022: $29.47 · 2023: $595 · 2024: $121 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.86 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $485.36 | 2023-2025 | Opdivo, Sotyktu, Augtyro |
| Merck Sharp & Dohme LLC | $232.25 | 2023-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $133.77 | 2021 | |
| Horizon Therapeutics Plc | $120.17 | 2023 | Uplizna |
| Amgen INC. | $118.85 | 2021-2023 | Blincyto, Kyprolis |
| Pfizer INC. | $99.06 | 2023 | |
| Astellas Pharma US INC | $84.99 | 2023 | |
| Genzyme Corporation | $33.36 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $32.28 | 2022-2023 | Libtayo |
| Pharmacyclics LLC, An Abbvie Company | $31.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.